TFAP2A and colorectal carcinoma: After the expression of TFAP2A was divided into high and low expression categories, we further assessed the correlation between TFAP2A mRNA expression and survival of patients, and found that higher expression of TFAP2A was correlated with poor overall survival of CRC patients (Fig. 7e, p < 0.05).